Glucotrack, Inc. Files 8-K
Ticker: GCTK · Form: 8-K · Filed: Oct 29, 2025 · CIK: 1506983
Sentiment: neutral
Topics: corporate-filing, disclosure
TL;DR
Glucotrack filed an 8-K on 10/29/25. Standard disclosure.
AI Summary
Glucotrack, Inc. filed an 8-K on October 29, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integrity Applications, Inc. and GlucoTrack, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ.
Why It Matters
This filing indicates routine corporate reporting and potential updates regarding financial statements or disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for corporate reporting and does not appear to contain significant new material events or risks.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- Integrity Applications, Inc. (company) — Former Company Name
- GlucoTrack, Inc. (company) — Former Company Name
- October 29, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Rutherford, NJ (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Glucotrack, Inc.?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits.
When was this 8-K filing submitted?
The filing was made on October 29, 2025.
What are Glucotrack, Inc.'s former company names?
Glucotrack, Inc. was formerly known as GlucoTrack, Inc. (name change effective March 28, 2022) and prior to that, Integrity Applications, Inc. (name change effective December 3, 2010).
Where is Glucotrack, Inc.'s principal executive office located?
The principal executive offices are located at 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.
In which state is Glucotrack, Inc. incorporated?
Glucotrack, Inc. is incorporated in Delaware.
Filing Stats: 491 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-10-29 16:19:12
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share GCTK The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 7KB
- 0001493152-25-020072.txt ( ) — 236KB
- gctk-20251029.xsd (EX-101.SCH) — 3KB
- gctk-20251029_lab.xml (EX-101.LAB) — 33KB
- gctk-20251029_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 29, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer